Page last updated: 2024-10-16
carnitine and Acute Onset Vascular Dementia
carnitine has been researched along with Acute Onset Vascular Dementia in 1 studies
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Although l-carnitine alleviated white-matter lesions in an experimental study, the treatment effects of l-carnitine on white-matter microstructural damage and cognitive decline in hemodialysis patients are unknown." | 8.02 | Possible Neuroprotective Effects of l-Carnitine on White-Matter Microstructural Damage and Cognitive Decline in Hemodialysis Patients. ( Andica, C; Aoki, S; Hattori, N; Io, H; Kamagata, K; Miyamoto, N; Motoi, Y; Nakata, J; Saito, A; Shiina, K; Shindo, A; Suzuki, Y; Taniguchi, D; Ueno, Y; Urabe, T; Yamashiro, K, 2021) |
"Although l-carnitine alleviated white-matter lesions in an experimental study, the treatment effects of l-carnitine on white-matter microstructural damage and cognitive decline in hemodialysis patients are unknown." | 4.02 | Possible Neuroprotective Effects of l-Carnitine on White-Matter Microstructural Damage and Cognitive Decline in Hemodialysis Patients. ( Andica, C; Aoki, S; Hattori, N; Io, H; Kamagata, K; Miyamoto, N; Motoi, Y; Nakata, J; Saito, A; Shiina, K; Shindo, A; Suzuki, Y; Taniguchi, D; Ueno, Y; Urabe, T; Yamashiro, K, 2021) |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Ueno, Y | 1 |
Saito, A | 1 |
Nakata, J | 1 |
Kamagata, K | 1 |
Taniguchi, D | 1 |
Motoi, Y | 1 |
Io, H | 1 |
Andica, C | 1 |
Shindo, A | 1 |
Shiina, K | 1 |
Miyamoto, N | 1 |
Yamashiro, K | 1 |
Urabe, T | 1 |
Suzuki, Y | 1 |
Aoki, S | 1 |
Hattori, N | 1 |
Other Studies
1 other study available for carnitine and Acute Onset Vascular Dementia
Article | Year |
---|---|
Possible Neuroprotective Effects of l-Carnitine on White-Matter Microstructural Damage and Cognitive Decline in Hemodialysis Patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Carnitine; Cognitive Dysfunction; Cross-Sectional Stu | 2021 |